Mostrar el registro sencillo del ítem
Environmental enrichment reverses tyrosine kinase inhibitor-mediated impairment through BDNF-TrkB pathway
dc.contributor.author | Bengoetxea H. | |
dc.contributor.author | Rico-Barrio I. | |
dc.contributor.author | Ortuzar N. | |
dc.contributor.author | Murueta-Goyena A. | |
dc.contributor.author | Lafuente J.V. | |
dc.date.accessioned | 2020-09-02T22:13:06Z | |
dc.date.available | 2020-09-02T22:13:06Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.1007/s12035-017-0716-y | |
dc.identifier.citation | 55, 1, 43-59 | |
dc.identifier.issn | 08937648 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/3731 | |
dc.description | Exposure to an enriched environment (EE) has neuroprotective benefits and improves recovery from brain injury due to, among other, increased neurotrophic factor expression. Through these neurotrophins, important cortical and hippocampal changes occur. Vandetanib acts as a tyrosine kinase inhibitor of cell receptors, among others, the vascular endothelial growth factor receptor (VEGFR). Our aim was to investigate the effectiveness of EE counteracting cognitive and cellular effects after tyrosine kinase receptor blockade. Animals were reared under standard laboratory condition or EE; both groups received vandetanib or vehicle. Visuospatial learning was tested with Morris water maze. Neuronal, interneuronal, and vascular densities were measured by inmunohistochemistry and histochemistry techniques. Quantifications were performed in the hippocampus and in the visual cortex. Brain-derived neurotrophic factor (BDNF), tyrosine kinase B receptor (TrkB), Akt, and Erk were measured by Western blot technique. Vandetanib produces a significant decrease in vascular and neuronal densities and reduction in the expression of molecules involved in survival and proliferation processes such as phospho-Akt/Akt and phospho- Erk/Erk. These results correlated to a cognitive impairment in visuospatial test. On the other hand, animals reared in an EE are able to reverse the negative effects, activating PI3K-AKT and MAP kinase pathways mediated by BDNF-TrkB binding. Present results provide novel and consistent evidences about the usefulness of living in EE as a strategy to improve deleterious effects of blocking neurotrophic pathways by vandetanib and the notable role of the BDNF-TrkB pathway to balance the neurovascular unit and cognitive effects. © Springer Science+Business Media, LLC 2017. | |
dc.language.iso | en | |
dc.publisher | Humana Press Inc. | |
dc.subject | Enriched environment | |
dc.subject | Hippocampus | |
dc.subject | Neuroprotection | |
dc.subject | Neurotrophins | |
dc.subject | Tyrosine kinase inhibitor | |
dc.subject | Visual cortex | |
dc.subject | brain derived neurotrophic factor | |
dc.subject | brain derived neurotrophic factor receptor | |
dc.subject | calbindin | |
dc.subject | calretinin | |
dc.subject | mitogen activated protein kinase | |
dc.subject | parvalbumin | |
dc.subject | protein kinase B | |
dc.subject | protein tyrosine kinase inhibitor | |
dc.subject | somatostatin | |
dc.subject | vandetanib | |
dc.subject | Bdnf protein, rat | |
dc.subject | brain derived neurotrophic factor | |
dc.subject | brain derived neurotrophic factor receptor | |
dc.subject | protein kinase inhibitor | |
dc.subject | protein tyrosine kinase | |
dc.subject | TrkB protein, rat | |
dc.subject | animal cell | |
dc.subject | animal experiment | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | brain region | |
dc.subject | cell density | |
dc.subject | cell proliferation | |
dc.subject | cell survival | |
dc.subject | cognition | |
dc.subject | cognitive defect | |
dc.subject | controlled study | |
dc.subject | dentate gyrus | |
dc.subject | environmental enrichment | |
dc.subject | hippocampus | |
dc.subject | immunohistochemistry | |
dc.subject | MAPK signaling | |
dc.subject | Morris water maze test | |
dc.subject | nerve cell | |
dc.subject | nonhuman | |
dc.subject | protein binding | |
dc.subject | protein function | |
dc.subject | quantitative analysis | |
dc.subject | rat | |
dc.subject | signal transduction | |
dc.subject | spatial learning | |
dc.subject | stereology | |
dc.subject | visual cortex | |
dc.subject | Western blotting | |
dc.subject | animal | |
dc.subject | antagonists and inhibitors | |
dc.subject | drug effect | |
dc.subject | environment | |
dc.subject | Long Evans rat | |
dc.subject | metabolism | |
dc.subject | physiology | |
dc.subject | signal transduction | |
dc.subject | Animals | |
dc.subject | Brain-Derived Neurotrophic Factor | |
dc.subject | Environment | |
dc.subject | Protein Kinase Inhibitors | |
dc.subject | Protein-Tyrosine Kinases | |
dc.subject | Rats | |
dc.subject | Rats, Long-Evans | |
dc.subject | Receptor, trkB | |
dc.subject | Signal Transduction | |
dc.title | Environmental enrichment reverses tyrosine kinase inhibitor-mediated impairment through BDNF-TrkB pathway | |
dc.type | Article |